The investigators will collect plasma samples at baseline, during treatment, and at progression.
patients treated with radiation therapy and cetuximab according to Bonner et al
patients treated with cetuximab in combination with chemotherapy according to Vermorken et al.
patients treated with a molecular targeted agent as a part of a clinical study
patients with another type of head and neck cancer
patients non treated with targeted therapies
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead sponsor